The DOI matches its Crossref record.
Monomeric Phospholamban Overexpression in Transgenic Mouse Hearts
Abstract
Abstract Phospholamban, a prominent modulator of the sarcoplasmic reticulum (SR) Ca 2+ -ATPase activity and basal contractility in the mammalian heart, has been proposed to form pentamers in native SR membranes. However, the monomeric form of phospholamban, which is associated with mutating Cys 41 to Phe 41 , was shown to be as effective as pentameric phospholamban in inhibiting Ca 2+ transport in expression systems. To determine whether this monomeric form of phospholamban is also functional in vivo, we generated transgenic mice with cardiac-specific overexpression of the mutant (Cys 41 →Phe 41 ) phospholamban. Quantitative immunoblotting indicated a 2-fold increase in the cardiac phospholamban protein levels compared with wild-type controls, with ≈50% of phospholamban migrating as monomers and ≈50% as pentamers upon SDS-PAGE. The mutant-phospholamban transgenic hearts were analyzed in parallel with transgenic hearts overexpressing (2-fold) wild-type phospholamban, which migrated as pentamers upon SDS-PAGE. SR Ca 2+ -uptake assays revealed that the EC 50 values for Ca 2+ were as follows: 0.32±0.01 μmol/L in hearts overexpressing monomeric phospholamban, 0.49±0.05 μmol/L in hearts overexpressing wild-type phospholamban, and 0.26±0.01 μmol/L in wild-type control mouse hearts. Analysis of cardiomyocyte mechanics and Ca 2+ kinetics indicated that the inhibitory effects of mutant-phospholamban overexpression (mt) were less pronounced than those of wild-type phospholamban overexpression (ov) as assessed by depression of the following: (1) shortening fraction (25% mt versus 45% ov), (2) rates of shortening (27% mt versus 48% ov), (3) rates of relengthening (25% mt versus 50% ov), (4) amplitude of the Ca 2+ signal (21% mt versus 40% ov), and (5) time for decay of the Ca 2+ signal (25% mt versus 106% ov) compared with control (100%) myocytes. The differences in basal cardiac myocyte mechanics and Ca 2+ transients among the animal groups overexpressing monomeric or wild-type phospholamban and wild-type control mice were abolished upon isoproterenol stimulation. These findings suggest that pentameric assembly of phospholamban is important for mediating its optimal regulatory effects on myocardial contractility in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, it has been shown that mutants promoting PLN oligomerization upregulate SERCA, whereas mutants that enhance deoligomerization down-regulate the ATPase, reducing Ca2+ flux and resulting in heart failure progression in mice models (Chu et al., 1997).”
From Structural dynamics and topology of phosphorylated phospholamban homopentamer reveal its role in the regulation of calcium transport (2013) · cites this paper as Chu et al., 1997
In the citing paper
“Keeping PLN regulation of SERCA within this physiological window requires maintaining a correct equilibrium between its monomeric and oligomeric states (Chu et al., 1997; Ha et al., 2011), its ability to be effectively phosphorylated (Ceholski et al., 2012; Said et al., 2003), net charge of the regulatory domain (Hou et al., 2008; Medeiros et al., 2011), and structural communication between TM and”
From Structural dynamics and topology of phosphorylated phospholamban homopentamer reveal its role in the regulation of calcium transport (2013) · cites this paper as Chu et al., 1997
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 28
- 10.1161/res.44.3.216505 · doi:10.1161/res.44.3.216505
- 10.1016/0167-4889(85)90090-4 · DOI
- 10.1161/res.79.6.1059 · doi:10.1161/res.79.6.1059
- 10.1016/S0021-9258(17)39680-1 · DOI · Paper page
- 10.1016/S0021-9258(18)69309-3 · DOI · Paper page
- 10.1016/S0021-9258(18)60487-9 · DOI · Paper page
- Talosi L, Edes I, Kranias EG. Intracellular mechanisms mediating reversal of beta-adrenergic stimulation in intact beating hearts. Am J Physiol. 1993;264:H791-H797.
- 10.1161/res.75.3.8062415 · doi:10.1161/res.75.3.8062415
- 10.1152/ajpcell.1996.271.1.C391 · DOI · Paper page
- 10.1161/res.77.3.632 · doi:10.1161/res.77.3.632
- 10.1172/JCI118446 · DOI · Paper page
- 10.1161/res.78.5.839 · doi:10.1161/res.78.5.839
- 10.1016/S0021-9258(19)40073-2 · DOI · Paper page
- 10.1016/S0021-9258(17)42051-5 · DOI · Paper page
- 10.1016/S0021-9258(18)45998-4 · DOI · Paper page
- 10.1042/bj3030511 · DOI
- 10.1016/S0021-9258(18)53845-X · DOI
- 10.1074/jbc.271.36.21726 · DOI · Paper page
- 10.1016/S0021-9258(19)89227-X · doi:10.1016/s0021-9258(19)89227-x
- 10.1016/S0021-9258(18)51579-9 · DOI · Paper page
- 10.1002/j.1460-2075.1994.tb06801.x · DOI · Paper page
- 10.1074/jbc.271.10.5941 · DOI · Paper page
- 10.1016/S0021-9258(19)81368-6 · DOI
- Bowman S, Tischfield JA, Stambrook PJ. An efficient and simplified method for producing site-directed mutations by PCR. Technique J Methods Cell Mol Biol. 1990;2:254-260.
- 10.1161/res.79.6.1064 · doi:10.1161/res.79.6.1064
- Dorn GW II, Robbins J, Ball N, Walsh RA. Myosin heavy chain regulation and myocyte contractile depression after LV hypertrophy in aortic-banded mice. Am J Physiol. 1994;267:H400-H405.
- 10.1038/nsb0295-154 · DOI · Paper page
- 10.1093/cvr/27.10.1766 · doi:10.1093/cvr/27.10.1766
Cited by
Phospholamban: Protein Structure, Mechanism of Action, and Role in Cardiac Function
SIMMERMAN, H. K. B., & JONES, L. R. (1998) · Physiological Reviews · doi:10.1152/physrev.1998.78.4.921 · Cited by 574
Schwinger, R. H. G., Münch, G., Bölck, B., Karczewski, P., Krause, E.-G., & Erdmann, E. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1998.0897 · Cited by 287
Periasamy, M., Reed, T. D., Liu, L. H., Ji, Y., Loukianov, E., Paul, R. J., Nieman, M. L., Riddle, T., Duffy, J. J., Doetschman, T., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2556 · Cited by 266
Thyroid hormone regulation of phospholamban phosphorylation in the rat heart
Ojamaa, K., Kenessey, A., & Klein, I. (2000) · Endocrinology · doi:10.1210/endo.141.6.7514 · Cited by 106
Vostrikov, V. V., Mote, K. R., Verardi, R., & Veglia, G. (2013) · Structure · doi:10.1016/j.str.2013.09.008 · Cited by 48
Metadata
- Authors
- Chu, G., Dorn, G. W., Luo, W., Harrer, J. M., Kadambi, V. J., Walsh, R. A., & Kranias, E. G.
- Affiliations
- From the Department of Pharmacology & Cell Biophysics (G.C., W.L., J.M.H., V.J.K., E.G.K.) and the Division of Cardiology of the Department of Internal Medicine (G.W.D., R.A.W.), University of Cincinnati (Ohio), College of Medicine.
- Venue
- Circulation Research
- Published
- 1997-10
- Volume
- 81
- Issue
- 4
- Pages
- 485-492
- ISSN
- 0009-7330
- 1524-4571
- Cited by
- 29
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Monomeric Phospholamban Overexpression in Transgenic Mouse Hearts. https://app.cochat.ai/papers/10.1161/01.res.81.4.485
- The paper
- Chu, G., Dorn, G. W., Luo, W., Harrer, J. M., Kadambi, V. J., Walsh, R. A., & Kranias, E. G. (1997). Monomeric Phospholamban Overexpression in Transgenic Mouse Hearts. Circulation Research. https://doi.org/10.1161/01.res.81.4.485
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.